Table 2.

Significant interaction effect of sFC and dFC of subregion in the cerebellum between BLT and placebo at pre and post-treatment.

Seeds	Significant regions	BA	voxels	MNI			F-statistic	Post VS. Pre (t, p)		BLT VS. Placebo (t, p)
				x	y	z		BLT	Placebo	Pre	Post
sFC
L Crus I	L Cerebellum Posterior Lobe	NA	37	−15	−63	−42	17.636	−1.474, 0.147	3.638, <0.001	0.300, 0.765	−4.065, < 0.001
L Crus II	Bilateral Cerebellum Posterior Lobe	NA	15	9	−57	−39	22.367	−2.576, 0.013	3.679, 0.001	1.469, 0.146	−4.066, < 0.001
R IX	L Cerebellum Posterior Lobe	NA	67	−18	−90	−30	20.314	−3.182, 0.003	3.323, 0.002	2.221, 0.029	−2.720, 0.008
	L Temporal Pole	38	42	−51	15	−30	14.827	2.413, 0.020	−4.221, < 0.001	−2.524, 0.013	3.184, 0.002
dFC
R IX	L SFG	9	23	−12	45	36	19.983	−3.126, 0.003	3.019, 0.004	3.141, 0.002	−3.071, 0.003

sFC, static functional connectivity; dFC, dynamic FC; BLT, bright light therapy; BA, Brodmann region; MNI, Montreal Neurological Institute; SFG, superior frontal gyrus; L, left; R, right.